307,094 Shares in Revvity, Inc. (NYSE:RVTY) Bought by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. bought a new position in Revvity, Inc. (NYSE:RVTY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 307,094 shares of the company's stock, valued at approximately $33,568,000. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.25% of Revvity at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of RVTY. Gladius Capital Management LP grew its holdings in shares of Revvity by 84.1% in the third quarter. Gladius Capital Management LP now owns 232 shares of the company's stock worth $26,000 after purchasing an additional 106 shares during the last quarter. CENTRAL TRUST Co bought a new position in shares of Revvity in the fourth quarter worth approximately $27,000. ORG Partners LLC bought a new position in shares of Revvity in the fourth quarter worth approximately $32,000. JTC Employer Solutions Trustee Ltd bought a new position in shares of Revvity in the fourth quarter worth approximately $33,000. Finally, Headinvest LLC bought a new position in shares of Revvity in the third quarter worth approximately $57,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Insider Activity

In other news, insider Prahlad R. Singh sold 21,217 shares of the firm's stock in a transaction on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the transaction, the insider now directly owns 92,801 shares in the company, valued at $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on RVTY shares. Stifel Nicolaus raised their price target on Revvity from $95.00 to $110.00 and gave the stock a "hold" rating in a research note on Friday, February 2nd. KeyCorp raised their price target on Revvity from $110.00 to $126.00 and gave the stock an "overweight" rating in a research note on Friday, February 2nd. Barclays raised their price target on Revvity from $92.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Thursday, January 25th. Evercore ISI raised Revvity from an "in-line" rating to an "outperform" rating and raised their price target for the stock from $88.00 to $125.00 in a research note on Thursday, January 4th. Finally, UBS Group lowered Revvity from a "buy" rating to a "neutral" rating and raised their price target for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $118.91.

Revvity Stock Up 1.5 %

Shares of NYSE:RVTY traded up $1.48 on Friday, hitting $100.86. 731,126 shares of the company traded hands, compared to its average volume of 981,722. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $135.67. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40. The stock has a 50 day simple moving average of $104.78 and a 200-day simple moving average of $101.56. The company has a market cap of $12.46 billion, a PE ratio of 18.34, a PEG ratio of 2.63 and a beta of 1.09.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. Revvity had a return on equity of 7.41% and a net margin of 25.20%. The firm had revenue of $695.90 million during the quarter. As a group, research analysts expect that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, April 19th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. Revvity's payout ratio is presently 5.09%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.